• Facebook
  • Instagram
  • Youtube
  • Linkedin
  • Twitter
  • Registry
  • ERBP
  • Working Groups
    • CKD-MBD
    • DESCARTES
    • DIABESITY
    • ERN
    • EUDIAL
    • EURECA-m
    • IWG
    • WGIKD
  • Committees
    • SAB
    • YNP
    • ECC
    • GNC
    • NPPC
    • Ethics Committee
    • Registry
    • ERBP
ERA-EDTA
  • ABOUT ERA-EDTA
      • WHO WE ARE
      • History
      • ERA-EDTA Facts and Dates
      • Pioneers of the European Nephrology
        • Interviews with the Masters of Nephrology
      • Obituaries
      • Mission
      • ORGANIZATION & GOVERNANCE
      • Council
        • Council Members
        • Past Council Members
        • Committees, Roles and Terms
        • Candidatures Boards and Calls
      • ORGANIZATION & GOVERNANCE
      • Group & Staff
        • ERA-EDTA
          • ERA-EDTA Operative Headquarters
        • ERA-Eurocongress Ltd
      • Constitution
      • Code of Conduct
      • Disclosure of Interest (DoI)
      • Annual Reports
      • Accounts
      • ERA-EDTA Membership
      • Benefits
      • Fees
      • Renewal
      • Members: Senior – Junior
      • Honorary Members
      • AWARDS
      • Awards 2020
      • Awards 2019
      • Awards 2018
      • ERA-EDTA Distinguished Fellow (FERA)
  • CONGRESS & MEETINGS
    • Berlin 2021
    • Paris 2022
    • Past Congresses
    • Scientific and Educational Interaction Day (SEID)
    • CTDay
    • CEPD
    • ERA-EDTA CME Courses
  • VIRTUAL MEETING
  • SCIENCE
    • Long Term Fellowships
    • Research Programme
    • Registry Fellowships
    • Registry
    • ERACODA
  • EDUCATION
    • NEP-Nephrology Education Portal
    • Virtual Meeting
    • e-seminars
    • GlomCon Webinars
    • Short Term Clinical Fellowships
    • ERA-EDTA CME Courses
    • Patient Information
      • Initiatives for patients
      • Patient Associations
    • ERA-EDTA Endorsement/Non-Financial Support
    • European Specialty Examination in Nephrology (ESENeph)
    • COVID-19 News and Information
  • NETWORKING
  • GUIDELINES
  • JOURNALS & PRESS
      • NDT
      • CKJ
      • Cardio-renal research
      • EDTA Proceedings
      • Newsletter & Press Releases
        • Nephrology News Flash
        • NEP Newsletter
        • Press Releases
      • News
      • EDTA Proceedings
      • Press and Social Media Policies
  • PUBLIC AFFAIRS
    • Collaboration with Societies
    • National Societies
      • National Societies of Nephrology List
    • ASN ERA-EDTA ISN Collaboration
    • EKHA
    • Biomedical Alliance in Europe
    • ERA-EDTA Endorsement/Non-Financial Support
    • Link Exchange
  • Search
  • Menu
  • My ERA-EDTA
  • Contact us
  • MEMBERSHIP
  • MEMBERSHIP
  • My Era-Edta
  • Contact us
  • ABOUT ERA-EDTA
    • Who we are
      • History
      • ERA-EDTA Facts and Dates
      • Mission
    • Organization & Governance
      • Council
        • Council Members
        • Past Council Members
        • Committees, Roles and Terms
    • Group & Staff
      • ERA-EDTA
      • ERA-EDTA Operative Headquarters
      • ERA-Eurocongress Ltd
      • Constitution
      • Code of Conduct
      • Annual Reports
      • Accounts
    • ERA-EDTA Membership
      • Benefits
      • Membership Fees
      • Renewal
      • Members: Senior – Junior
    • AWARDS
      • Awards 2020
      • Awards 2019
      • Awards 2018
      • ERA-EDTA Distinguished Fellow (FERA)
  • CONGRESS & MEETINGS
    • Berlin 2021
    • Paris 2022
    • Scientific and Educational Interaction Day (SEID)
    • CTDay
    • CEPD
    • ERA-EDTA CME Courses
  • VIRTUAL MEETING
  • SCIENCE
    • Long Term Fellowships
    • Research Programme
    • Registry Fellowships
    • Registry
    • ERACODA
  • EDUCATION
    • NEP-Nephrology Education Portal
    • Virtual Meeting
    • e-seminars
    • GlomCon Webinars
    • Short Term Clinical Fellowships
    • ERA-EDTA CME Courses
    • Initiatives for patients
    • Patient Associations
    • ERA-EDTA Endorsement/Non-Financial Support
    • European Specialty Examination in Nephrology (ESENeph)
    • COVID-19 News and Information
  • NETWORKING
  • GUIDELINES
  • JOURNALS & PRESS
    • NDT
    • CKJ
    • Cardio Renal Research
    • Newsletter & Press Releases
      • Nephrology News Flash
      • NEP-Nephrology Education Portal Newsletters
      • Press Releases
    • News
    • EDTA PROCEEDINGS
    • Press and Social Media Policies
  • PUBLIC AFFAIRS
    • Collaboration with Societies
    • National Societies
    • ASN ERA-EDTA ISN Collaboration
    • EKHA
    • ERA-EDTA Endorsement/Non-Financial Support
    • Link Exchange
  • Registry
  • ERBP
  • Working Groups
    • CKD-MBD
    • DESCARTES
    • DIABESITY
    • ERN
    • EUDIAL
    • EURECA-m
    • IWG
    • WGIKD
  • Committees
    • SAB
    • YNP
    • ECC
    • GNC
    • NPPC
    • Ethics Committee
    • Registry
    • ERBP

Tag Archive for: hypertension

Posts

Clinical considerations and strategies for treating hypertension in CKD patients

News, News-Home

Hypertension is both a major cause and consequence of chronic kidney disease (CKD). It is associated with increased risk of cardiac events, stroke and kidney disease progression. The latest National Kidney Foundation Clinical Practice Guidelines recommend a blood pressure goal of <130mmHg systolic and <80mmHg diastolic for all CKD patients, regardless of the level of albuminuria. Several non-pharmacological interventions are recommended to achieve this, including weight loss, salt intake restriction and physical activity. As for pharmacological treatment, a combination of renin-angiotensin system (RAS) blocker (either ACE inhibitor or ARB, in case of ACE inhibitor intolerance) with a calcium channel blocker or a diuretic is recommended as initial therapy in patients with CKD stage 3 or higher. A combination of two RAS blockers is not recommended

Read the article https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfz279/5700448

31 January 2020/by ERA-EDTA
https://www.era-edta.org/en/wp-content/uploads/2019/10/patient_img_home.jpg 700 1000 ERA-EDTA ERA-EDTA2020-01-31 11:36:442020-01-31 11:36:44Clinical considerations and strategies for treating hypertension in CKD patients

Hypertension guidelines for CKD patients make practicing physicians confused

News, News-Home

In a new CKJ review article, authors discuss the similarities and differences between three major guidelines that deal with hypertension and CKD and call for unified basic concepts to prevent confusion among patients and physicians.

Three major guidelines deal with blood pressure thresholds and targets for hypertensive drug therapy in CKD patients: the 2012 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline; the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline and the 2018 European Society of Cardiology (ESC)/European Society of Hypertension (ESH) Guidelines. However, reading the three guidelines leaves the practicing physician confused about the definition of CKD, how hypertension and secondary hypertension should be diagnosed in CKD patients and what the BP thresholds and targets for antihypertensive drug therapy should be for this population. In a new CKJ review article, authors discussthe similarities and differences between these guidelines and call for unified basic concepts to prevent confusion among patients and physicians.

Find the paper in the CKJ here

14 October 2019/by ERA-EDTA
https://www.era-edta.org/en/wp-content/uploads/2019/10/patient_img_home.jpg 700 1000 ERA-EDTA ERA-EDTA2019-10-14 15:49:392019-10-17 15:51:58Hypertension guidelines for CKD patients make practicing physicians confused

SPRINT trial results: Serum bicarbonate and cardiovascular events in hypertensive adults

News-Home

In hypertensive individuals, serum bicarbonate level <22 mEq/L was associated with an increased CVD risk. The effect of intensive BP lowering on CVD outcomes was not modified by the serum bicarbonate level.

Serum bicarbonate concentration <22 mEq/L is independently associated with a high risk of cardiovascular disease (CVD) events in hypertensive individuals, according to the results of a recently published study in the NDT. The effect of intensive blood pressure lowering on CVD outcomes was not modified by the serum bicarbonate level. Future studies should determine the underlying mechanisms linking hypobicarbonatemia with these adverse outcomes, with particular attention to the underlying acid–base abnormality, and should assess if the treatments to correct such abnormality lead to improved CVD outcomes.

Find the paper here

5 September 2019/by ERA-EDTA
https://www.era-edta.org/en/wp-content/uploads/2019/10/12_sb.png 1124 1900 ERA-EDTA ERA-EDTA2019-09-05 12:05:112019-10-01 12:11:27SPRINT trial results: Serum bicarbonate and cardiovascular events in hypertensive adults

Pages

GlomCon Webinars

Magnetic Resonance Imaging to Assess Renal Tissue Oxygenation and Function a BOLD story.


Speaker: Menno Pruijm


Panelists: Sue Francis, Nicholas Selby, Keith Gillis, Charlotte Buchanan


Moderators: Kate Stevens, Dia Waguespack


Tuesday, December 8, 5 pm CET/4 pm GMT/ 8 am PT


Meeting ID: 937 9592 6539 Passcode 202122



CLICK HERE TO JOIN THE WEBINAR

New Glucose-Lowering Drugs and Kidney Protection in CKD


Speaker: Brendon Neuen


Panelists: Christoph Wanner, James Boyle, Maria José Soler


Moderator: Kate Stevens


Tuesday, November 10, 5 pm CET/4 pm GMT/ 8 am PT



CLICK HERE TO WATCH THE WEBCAST

Renal Toxicity Associated with New Immunotherapies


Dr. Juliana Bordignon Draibe


Tuesday, September 8, 5 pm CEST/4 pm GMT/ 8 am PST



Click on the image to view the webinar webcast.

PKD Throughout life

ARPKD in adults and ADPKD in Children

 


Dr. Max Liebau


Tuesday, March 10, 5 pm CET/4 pm GMT/ 8 am PST



Click on the image to view the webcast

Trends in Excess Mortality in European Adult Patients on Renal Replacement Therapy


Dr. Rianne Boenink


Tuesday, February 11, 5 pm CET/4 pm GMT/ 8 am PST

microRNA: From Physiology to Disease – Applications in Nephrology


Dr. Anastasiia Rind


Tuesday, January 14, 5 pm CET/4 pm GMT/ 8 am PST



Click on the image to view the webcast.

Management of HSP Nephritis: What can the Adult Nephrologist learn from the Pediatric Experience?


Dr. Louise Oni


Tuesday, December 10, 5 pm CET/4 pm GMT



Click on the image to view the webcast.

Sodium Bicarbonate and Cardiovascular Events in Hypertensive Adults: Results from SPRINT


Dr. Mirela Dobre


Tuesday, November 11, 5 pm CET/4 pm GMT



Click on the image to view the webcast.

Picks of the new European Renal Best Practice Guidelines on Vascular


Dr. Sokratis Stoumpos


Tuesday, October 8, 5 pm CET/4 pm GMT



Click on the image to view the webcast.

7 October 2019/by ERA-EDTA
https://www.era-edta.org/en/wp-content/uploads/2020/05/webinair.jpg 670 1056 ERA-EDTA ERA-EDTA2019-10-07 10:46:142020-12-04 10:32:39GlomCon Webinars
  • The risks of gastrointestinal adverse events with initiation of sodium polystyrene sulphonate19 October 2020 - 10:55
  • Are all donated kidneys the same?16 October 2020 - 11:40
  • Which phosphate transporters should be targeted to reduce hyperphosphatemia?14 October 2020 - 10:02
  • Does ADH modulate renal calcium excretion in patients with CDI and hypercalciuria?12 October 2020 - 16:31

ERA-EDTA Operative Headquarters
Via XXIV Maggio 38
43123 Parma – Italy
Phone: +39 0521 989078
Fax: +39 0521 959242
E-mail: secretariat@era-edta.org

ERA-EDTA Registered Office
c/o PKF Littlejohn, 15 Westferry Circus, Canary Wharf
London E14 4HD – United Kingdom

You are here: Home / hypertension

  • ABOUT ERA-EDTA
  • CONGRESS & MEETINGS
  • JOURNAL & PRESS
  • EDUCATION
  • PUBLIC AFFAIRS
  • GUIDELINES

  • My ERA-EDTA
  • Contact us
  • MEMBERSHIP
.av-share-box ul li{ display: none!important; }

  • Share on Facebook
  • Share on Twitter
  • Share on Pinterest
  • Share on Linkedin
  • Share on Reddit
  • Share by Mail
  • Share on WhatsApp
© Copyright - Era-Edta
  • Terms and Conditions
  • Cookie Policy
  • Privacy Policy
  • Facebook
  • Instagram
  • Youtube
  • Linkedin
  • Twitter
Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

OKLearn more